TY - JOUR
T1 - pH-Responsive Charge-Conversion Progelator Peptides
AU - Carlini, Andrea S.
AU - Choi, Wonmin
AU - McCallum, Naneki C.
AU - Gianneschi, Nathan C.
N1 - Funding Information:
The authors would like to thank M. Touve for assistance with TEM, S. Shafaie and A. Gaisin for aid with MS and LC experiments, M. Thompson for NMR processing, and M. Vratsanos for assistance with hemocompatibility studies. Thanks to the Molinski Lab at UC San Diego for the use of their CD spectrometer. Thank you to the Ameer Lab at Northwestern University for the use of their Hemochron instrument. Finally, this work made use of the MatCI and IMSERC NMR facilities at Northwestern University, which receives support from the MRSEC Program (NSF DMR‐1720139) of the Materials Research Center, Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS‐1542205), International Institute of Nanotechnology, and Northwestern University. The work was supported by an NIH Director's Transformative Research Award (R01HL117326), part of the NIH Common Fund; the NHLBI (R01HL139001); the DoD through an ARO (W911NF‐17‐1‐0326), ARO MURI (W911NF‐15‐1‐0568), and an AFOSR MURI (FA9550‐16‐1‐0150).
Funding Information:
The authors would like to thank M. Touve for assistance with TEM, S. Shafaie and A. Gaisin for aid with MS and LC experiments, M. Thompson for NMR processing, and M. Vratsanos for assistance with hemocompatibility studies. Thanks to the Molinski Lab at UC San Diego for the use of their CD spectrometer. Thank you to the Ameer Lab at Northwestern University for the use of their Hemochron instrument. Finally, this work made use of the MatCI and IMSERC NMR facilities at Northwestern University, which receives support from the MRSEC Program (NSF DMR-1720139) of the Materials Research Center, Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205), International Institute of Nanotechnology, and Northwestern University. The work was supported by an NIH Director's Transformative Research Award (R01HL117326), part of the NIH Common Fund; the NHLBI (R01HL139001); the DoD through an ARO (W911NF-17-1-0326), ARO MURI (W911NF-15-1-0568), and an AFOSR MURI (FA9550-16-1-0150).
Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2021/3/24
Y1 - 2021/3/24
N2 - A simple strategy for generating stimuli-responsive peptide-based hydrogels via charge-conversion of a self-assembling peptide (SAP) is described. These materials are formulated as soluble, polyanionic peptides, containing maleic acid, citraconic acid, or dimethylmaleic acid amide masking groups on each lysine residue, which do not form assemblies, but instead flow easily through high gauge needles and catheters. Acid-induced mask hydrolysis renews the zwitterionic nature of the peptides with concomitant and rapid self-assembly via β-sheet formation into rehealable hydrogels. The use of different masks enables one to tune pH responsiveness and assembly kinetics. In anticipation of their potential for in vivo hydrogel delivery and use, progelators exhibit hemocompatibility in whole human blood, and their peptide components are shown to be noncytotoxic. Finally, demonstration of stimuli-induced self-assembly for dye sequestration suggests a simple, non-covalent strategy for small molecule encapsulation in a degradable scaffold. In summary, this simple, scalable masking strategy allows for preparation of responsive, dynamic self-assembling biomaterials. This work sets the stage for implementing biodegradable therapeutic hydrogels that assemble in response to physiological, disease-relevant states of acidosis.
AB - A simple strategy for generating stimuli-responsive peptide-based hydrogels via charge-conversion of a self-assembling peptide (SAP) is described. These materials are formulated as soluble, polyanionic peptides, containing maleic acid, citraconic acid, or dimethylmaleic acid amide masking groups on each lysine residue, which do not form assemblies, but instead flow easily through high gauge needles and catheters. Acid-induced mask hydrolysis renews the zwitterionic nature of the peptides with concomitant and rapid self-assembly via β-sheet formation into rehealable hydrogels. The use of different masks enables one to tune pH responsiveness and assembly kinetics. In anticipation of their potential for in vivo hydrogel delivery and use, progelators exhibit hemocompatibility in whole human blood, and their peptide components are shown to be noncytotoxic. Finally, demonstration of stimuli-induced self-assembly for dye sequestration suggests a simple, non-covalent strategy for small molecule encapsulation in a degradable scaffold. In summary, this simple, scalable masking strategy allows for preparation of responsive, dynamic self-assembling biomaterials. This work sets the stage for implementing biodegradable therapeutic hydrogels that assemble in response to physiological, disease-relevant states of acidosis.
KW - catheter
KW - charge-conversion
KW - hemocompatible
KW - hydrogels
KW - pH-responsive
KW - peptides
KW - self-assembly
UR - http://www.scopus.com/inward/record.url?scp=85099333077&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099333077&partnerID=8YFLogxK
U2 - 10.1002/adfm.202007733
DO - 10.1002/adfm.202007733
M3 - Article
C2 - 36530181
AN - SCOPUS:85099333077
SN - 1616-301X
VL - 31
JO - Advanced Functional Materials
JF - Advanced Functional Materials
IS - 13
M1 - 2007733
ER -